Splice-site mutations in atherosclerosis candidate genes relating individual information to phenotype

Circulation

Volumn 100, Issue 7, 1999, Pages 693-699

  Von Kodolitsch, Yskert ^a   Pyeritz, Reed E ^b   Rogan, Peter K ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b ALLEGHENY GENERAL HOSPITAL   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Atherosclerosis; Genetics; Lipids; Risk factors; RNA

Indexed keywords

NUCLEOTIDE;

AMINO ACID METABOLISM; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE SEVERITY; DYSLIPIDEMIA; GENE MUTATION; HUMAN; LIPID METABOLISM; PHENOTYPE; PRIORITY JOURNAL; RNA SPLICING;

EID: 0033578466     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.7.693     Document Type: Article

References (45)

1. Mehrabian M, Lusis AJ. Genetic markers for studies of atherosclerosis and related risk factors. In: Lusis AJ, Rotter JI, Sparkes RS. eds. Molecular Genetics of Coronary Artery Disease: Candidate Genes and Process in Atherosclerosis. Vol 14. Basel: Karger; 1992;363-418.
2. Rogan PK, Faux BM, Schneider TD. Information analysis of human splice site mutations. Hum Mutat. 1998;12:153-171.
3. Stephens RM, Schneider TD. Features of spliceosome evolution and function inferred from an analysis of the information at human splice sites. J Mol Biol. 1992;228:1124-1136.
4. Schneider TD. Information content of individual genetic sequences. J Theor Biol. 1997;189:427-441.
5. Krawczak M, Cooper DN. The human gene mutation database. Trends Genet. 1997;13:121-122.
6. Reed R, Maniatis T. A role for exon sequences and splice site proximity in splice site selection. Cell. 1996;46:681-690.
7. Schneider TD. Sequence walkers: a graphical method to display how binding proteins interact with DNA or RNA sequences. Nucleic Acids Res. 1997;25:4408-4415.
8. Rogan PK, Schneider TD. Using information content and base frequencies to distinguish mutations from genetic polymorphisms in splice junction recognition sites. Hum Mutat. 1995;6:74-76.
9. Sakai N, Santamarina-Fojo S, Yamashita S, Matsuzawa Y, Brewer HB Jr. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J Lipid Res. 1996;37:2065-2073.
10. Chimienti G, Capurso A, Resta F, Pepe G. G→C change at the donor splice site of intron 1 causes lipoprotein lipase deficiency in a southern-Italian family. Biochem Biophys Res Commun. 1992;187:620-627.
11. Sun XM, Patel DD, Bhatnagar D, Knight BL, Soutar AK. Characterization of a splice-site mutation in the gene for the LDL receptor associated with an unpredictably severe clinical phenotype in English patients with heterozygous FH. Arterioscler Thromb Vasc Biol. 1995;15: 219-227.
12. Jensen HK, Jensen LG, Hansen PS, Bolund L, Færgeman O, Gregersen N. Two point mutations (313+1G→A and 313+1G→T) in the splice donor site of intron 3 of the low-density lipoprotein receptor gene are associated with familial hypercholesterolemia. Hum Mutat. 1996;7: 269-271.
13. Gudnason V, Sigurdsson G, Nissen H, Humphries SE. Common founder mutation in the LDL receptor gene causing familial hypercholesterolemia in the Iceland population. Hum Mutat. 1997;10:36-44.
14. Pagani F, Garcia R, Pariyarath R, Stuani C, Gridelli B, Paone G, Baralle FE. Expression of lysosomal acid lipase mutants detected in three patients with cholesteryl ester storage disease. Hum Mol Genet. 1996;5: 1611-1617.
15. Muntoni S, Wiebusch H, Funke H, Ros E, Seedorf U, Assmann G. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet. 1995;95:491-494.
16. Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest. 1993;92:2713-2718.
17. Hölzl B, Huber R, Paulweber B, Patsch JR, Sandhofer F. Lipoprotein lipase deficiency due to a 3′ splice site mutation in intron 6 of the lipoprotein lipase gene. J Lipid Res. 1994;35:2161-2169.
18. Deeb SS, Takata K, Peng R, Kajiyma G, Albers JJ. A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet. 1990;46:822-827.
19. Huang L-S, Kayden H, Sokol RJ, Breslow JL. APOB gene nonsense and splicing mutations in a compound heterozygote for familial hypobetalipoproteinemia. J Lipid Res. 1991;32:1341-1348.
20. Hamburg) in a patient with APOCII deficiency. J Clin Invest. 1988;82:1489-1494.
21. 244 and transition in 3′ splice site of intron 2 (AG→AA) in the lipoprotein lipase gene. Am J Hum Genet. 1990;47:721-726.
22. Top B, van der Zee A, Havekes LM, van't Hooft, Frants RR. Identification of a splice-site mutation in the low density lipoprotein receptor gene by denaturing gradient gel electrophoresis. Hum Genet. 1993;91: 480-484.
23. Ekström U, Abrahamson M, Sveger T, Lombardi P, Nilsson-Ehle P. An efficient screening procedure detecting six novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia. Hum Genet. 1995;96:147-150.
24. Leren TP, Solberg K, Rødningen OK, Tonstad S, Ose L. Two novel point mutations in the EGF precursor homology domain of the LDL receptor gene causing familial hypercholesterolemia. Hum Genet. 1995;96: 241-242.
25. Maruyama T, Miyake Y, Tajima S, Harada-Shiba M, Yamamura T, Tsushima M, Kishino B, Horiguchi Y, Funahashi T, Matsuzawa Y. Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population. Arterioscler Thromb Vasc Biol. 1995;15:1713-1718.
26. Funahashi T, Yamashita S, Maruyama T, Ueyama Y, Menju M, Nagali Y, Takemura K, Miyake Y, Tajima S, Matsuzawa Y. A compound heterozygote for familial hypercholesterolemia with homozygous mother. J Intern Med. 1996;239:187-190.
27. Gotoda T, Senda M, Murase T, Yamada N, Takaku F, Furuichi Y. Gene polymorphism identified by Pvull in familial lipoprotein lipase deficiency. Biochem Biophys Res Commun. 1989;164:1391-1396.
28. Gotoda T, Yamada N, Kawamura M, Kozaki K, Mori N, Ishibashi S, Shimano H, Takaku F, Yazaki Y, Furuichi Y, Murase T. Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest. 1991;88:1856-1864.
29. Lelli N, Garuti R, Ghisellini M, Tiozzo R, Rolleri M, Aimale V, Ginocchio E, Naselli A, Bertolini S, Calandra S. Occurrence of multiple aberrantly spliced mRNAs of the LDL-receptor gene upon a donor splice site mutation that causes familial hypercholesterolemia (FHBenevento). J Lipid Res. 1995;36:1315-1324.
30. Cladaras C, Hadzopoulou-Cladaras M, Felber BK, Pavlakis G, Zannis VI. The molecular basis of a familial APOE deficiency: an acceptor splice site mutation in the third intron of the deficient APOE gene. J Biol Chem. 1987;262:2310-2315.
31. Schaefer EJ, Gregg RE, Ghiselli G, Forte TM, Ordovas JM, Zech LA, Bewer HB Jr. Familial apolipoprotein E deficiency. J Clin Invest. 1986; 78:1206-1219.
32. Talmud PJ, Krul ES, Pessah M, Gay G, Schonfeld G, Humphries SE, Infante R. Donor splice mutation generates a lipid-associated apolipoprotein B-27.6 in a patient with homozygous hypobetalipoproteinemia. J Lipid Res. 1994;35:468-477.
33. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989;342:448-451.
34. Koizumi J, Mabuchi H, Yoshimura A, Michishita I, Takeda M, Itoh H, Sakai Y, Ueda K, Takeda R. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinemia. Atherosclerosis. 1985;58:175-186.
35. Koivisto U-M, Viikari JS, Kontula K. Molecular characterization of minor gene rearrangements in Finnish patients with heterozygous familial hypercholesterolemia: identification of two common missense mutations (Gly823→Asp and Leu380→His) and eight rare mutations of the LDL receptor gene. Am J Hum Genet. 1995;57:789-797.
36. Pereira E, Ferreira R, Hermelin B, Thomas G, Bernard C, Bertrand V, Nassiff H. Del Castillo DM, Bereziat G, Benlian P. Recurrent and novel LDL receptor gene mutations causing heterozygous familial hypercholesterolemia in La Habana. Hum Genet. 1995;96:319-322.
37. Kuivenhoven JA, Weibusch H, Pritchard PH, Funke H, Benne R, Assmann G, Kastelein JJP. An intronic mutation in a lariat branchpoint is a direct cause of an inherited human disorder (fish eye disease). J Clin Invest. 1996;98:358-364.
38. Jensen HK, Jensen LG, Hansen PS, Faergeman O, Gregersen N. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin Chem. 1996;42:1140-1146.
39. Sundvold H, Solberg K, Tonstad S, Rødningen OK, Ose L, Berg K, Leren TP. A common missense mutation (C210G) in the LDL receptor gene among Norwegian familial hypercholesterolemia subjects. Hum Mutat. 1996;7:70-71.
40. Day INM, Whittall RA, O'Dell SD, Haddad L, Bolla MK, Gudnason V, Humphries SE. Spectrum of LDL receptor gene mutations in heterozygous familial hypercholesterolemia. Hum Mutat. 1997;10:116-127.
41. Hobbs HH, Brown MS, Goldstein TL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat. 1992;1: 445-466.
42. Bruin T, Tutzgöl S, van Diermen DE, Hoogerbrugge-van der Linden N, Brunzell JD, Hayden MR, Kastelein JJP. Recurrent pancreatitis and chylomicronemia in an extended Dutch kindred is caused by Gly15→Ser substitution in lipoprotein lipase. J Lipid Res. 1993;34:2109-2119.
43. Webb JC, Patel DD, Shoulders CC, Knight BL, Soutar AK. Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein(LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolemia and a common polymorphism. Hum Mol Genet. 1996;5:1325-1331.
44. Heidberg A. The risk of atherosclerotic vascular disease in subjects with xanthomatosis. Acta Med Scand. 1975;198:249-261.
45. Morganroth J, Levy RI, Fredrickson DS. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med. 1975; 82:158-174.